Pentaerithrityl Tetranitrate (PETN) for Secondary Prevention of Intrauterine Growth Restriction

NCT03669185 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

324

Enrollment

OTHER

Sponsor class

Conditions

Fetal Growth Retardation
Pregnancy Related
Intrauterine Growth Restriction

Interventions

DRUG: Pentalong
DRUG: Placebos

Sponsor

Jena University Hospital